Products 56985-32-1

CAS 56985-32-1 appears in our catalog under these names: U–44069, U-44069, 9,11-DIDEOXY-9A,11A-EPOXYMETHANO- &, U-44069, 98.0%. Offered by: GLPBio, TRC, Sigma-Aldrich, MedChemExpress. Available pack sizes: 1mg, 25mg, 10mg, 5mg, 1 mg (28.53 mM * 100 μL in Methyl acetate).

U–44069
GLPBio
  • size: 1mg, 10mg, 5mg
  • Variants: 3
from 1420.81
View product
U-44069
TRC
  • size: 25mg
  • Variants: 1
View product
9,11-DIDEOXY-9A,11A-EPOXYMETHANO- &
Sigma-Aldrich
  • size: 1MG, 5MG
  • Variants: 2
from 1240.00
View product
U-44069, 98.0%
MedChemExpress
  • size: 1 mg (28.53 mM * 100 μL in Methyl acetate)
  • Variants: 1
from 1847.57
View product
Structural formula: {0} (CAS {1})

U-44069 is a prostanoid.

Source: ChEBI

Identity
Molecular formulaC21H34O4
Molecular weight350.5 g/mol
IUPAC name(Z)-7-[(1S,4R,5S,6R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-6-yl]hept-5-enoic acid
InChIKeyDJKDIKIDYDXHDD-IGUVKOCZSA-N
SMILESCCCCC[C@@H](/C=C/[C@H]1[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)OC2)O

Computed by PubChem (NCBI)

Synonyms: 9,11-Epoxymethanoprostaglandin H2, 9,11-Dideoxy-9alpha,11alpha-epoxymethanoprostaglandin F2alpha (U-44069)
Related forms of this compound
(E)-7-[(5S,6R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-6-yl]hept-5-enoic acid C21H34O4
Isomers (same molecular formula)
1-[(3R,5R,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4
1-[(3R,5R,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
methyl (8E,11E,14E,17E)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O4
1-[(3S,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(3S,5R,8S,9S,10S,13S,14R,17R)-3,17-dihydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4